Company intelligence / Profile preview

Guangdong Jibao Pharmaceutical Technology

Likely Guangzhou (not explicitly confirmed), Guangdong Sheng, Chinajiabopharma.com ↗

Ownership: Private
Employees: ~500
Development stage: Other

Overview

Guangdong Jiabo Pharmaceutical is a leading Chinese pharmaceutical company focused on perioperative fields and complex injectable drugs; its main product, Propofol Medium and Long Chain Fat Emulsion Injection, is commercially available and has won national innovation awards[1][3][4][5][7][10].

Therapeutic areas: Other
Modalities: Small moleculeFat emulsionLiposome
Industry: Biotech

Partnerships

Production, Study & Research Base of Sun Yat-sen University[5]Guangdong Intravenous Fat Emulsion Engineering Technology Research Center[1][5]Guangdong Postdoctoral Innovation Practice Base[1][5]

Beyond the preview

Go deeper on Guangdong Jibao Pharmaceutical Technology.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Guangdong Jibao Pharmaceutical Technology.